Why is Pfizer stock falling after Q3 results?
Pfizer (PFE) stock fell even as the company beat forecasts with its Q3 results and increased its full-year outlook.Find out ...
Pfizer’s Balanced Outlook: Hold Rating Amid Strong Q3 Results and Future Challenges
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00.
BioSpace14h
Pfizer Exceeds Wall Street’s Q3 Expectations Amid Activist Investor Pressure
CEO Albert Bourla, who is under attack from activist investor Starboard Value, got a much-needed victory on Tuesday as Pfizer ...
Pfizer, McDonald’s Q3 Earnings to Set Early Market Tone; Alphabet, AMD Follow Post-Close
Pfizer’s rebound and McDonald’s E. coli impact headline pre-market earnings; post-close focus shifts to Alphabet and AMD. Get ...
Why Pfizer Stock Tumbled on Tuesday
Well before market open, Pfizer unveiled those quarterly results. These showed that the company's revenue was $17.7 billion, for a strong 32% year-over-year improvement when factoring sales of Covid ...